Endovascular Engineering, Inc. ("E2") has secured $42 million in an oversubscribed Series B financing to advance its next generation clot removal technology platform for venous thromboembolism (VTE).

B.C.'s NDP government laid out its priorities for 2025 amid a backdrop of looming U.S. trade tariffs and a record-high ...

Take a look back at movies that explore worlds in which viruses and diseases (or related metaphors) run rampant.

Crypto has a window—especially before 2026 midterm elections when Republican congressional control might be weakened—to move ...

Are seed oils or animal fats, like butter and tallow, better for you? Experts discuss the benefits and downsides, and the ...

The discovery of a 'biomarker panel' could have a profound impact on the ability to identify patients at risk of developing ...

Sweeping layoffs, funding freezes and executive orders have provoked outcry among federal researchers and their university partners, who fear that science itself is under siege.

Rocket Doctor partners with new Managed Care Plan serving ~450,000 California Medicaid membersFuture anticipated additional ARR of ~US$1.2 ...

Bedfont ® Scientific Limited partners with Selig De Colombia to bring the Gastrolyzer® range of HMBT devices to Colombia.

Company shares preliminary results from Phase 1/2 clinical trial for patients with advanced Retinitis Pigmentosa (RP)NEW YORK, Feb. 18, 2025 ...

Per Reuters, 20 people who worked in the FDA’s office of neurological and physical medicine devices got axed as part of a ...

The cuts in funding to Cold Spring Harbor Laboratory are one of many being proposed to science and research centers across ...